Atlas Trials

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Clinical trial NCT00838201 · COMPLETED

Trial details

NCT number
NCT00838201
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
CancerCarcinomaCastrate-Resistant Prostate CancerProstate CancerTumors
Start date
2009-02-01
Primary completion
2012-05-03
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.